This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Simovay Pharmaceutical Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Yao Hua - Innovator in Pharmaceutical Chemistry
Introduction
Yao Hua is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on naphthyridine derivatives. His research focuses on developing compounds that have the potential to treat various medical conditions.
Latest Patents
Yao Hua holds a patent for a compound titled "1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof." This patent describes the 1,4-dihydro-naphthyridine derivatives, which are capable of inhibiting acetylcholinesterase activity. These compounds also prevent extracellular calcium from flowing into a cell via a calcium channel, showcasing their dual activity. This innovation is of potential importance in the pharmaceutical industry, particularly for preparing drugs aimed at treating cardiovascular diseases, cerebrovascular diseases, and dementia. He has 1 patent to his name.
Career Highlights
Yao Hua is currently associated with Jiangsu Simovay Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical sector, contributing to the development of new therapeutic agents.
Collaborations
Yao has collaborated with notable colleagues, including Rong Chen and Lin Feng, who have supported his research endeavors. Their combined expertise has enhanced the impact of their work in the pharmaceutical field.
Conclusion
Yao Hua's innovative contributions to pharmaceutical chemistry, particularly through his patent on naphthyridine derivatives, highlight his role as a significant inventor in the industry. His ongoing work promises to lead to advancements in treatments for critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile